title: Gelofusine affects the quality control performance of QuickVue point-of-care human chorionic gonadotropin test devices.
abstract: OBJECTIVE
  To characterize the influence of Gelofusine (succinylated gelatin) on the performance of point-of-care testing (POCT) for human chorionic gonadotropin (hCG) devices.
  
  
  METHODS
  Three brands of urine and urine/serum hCG POCT devices were verified.
  
  
  RESULTS
  Succinylated gelatin affected the performance of the control band in the QuickVue hCG POCT devices. Alternative devices were not affected. The hCG test performance is not influenced.
  
  
  CONCLUSIONS
  Gelofusine affects specifically the quality control performance of the QuickVue hCG POCT devices.
authors: Department of Clinical Chemistry, Maastricht University Medical Centre, The Netherlands. douwe.de.boer@mumc.nl
authors: Douwe
authors: D
authors: de Boer
authors: Christel
authors: C
authors: Houben
authors: Otto
authors: O
authors: Bekers
authors: Paul P C A
authors: PP
authors: Menheere
mesh_terms: D006063:Chorionic Gonadotropin; D005260:Female; D006801:Humans; D019095:Point-of-Care Systems / Q000592:standards*; D011097:Polygeline; D011786:Quality Control; D011933:Reagent Kits, Diagnostic / Q000592:standards*
chemical_list: D006063:Chorionic Gonadotropin; D011933:Reagent Kits, Diagnostic; D011097:Polygeline